Decreasing Trends in Cervical Cancer Incidence among Young Women (15–34 Years) in the United States during the Human Papillomavirus (HPV) Vaccine Era

Human papillomavirus (HPV) vaccine has been recommended for girls 11–12 years of age since 2006, with catch-up vaccination up to 26 years, to protect against most common types of HPV that cause cervical cancer. Cervical cancer incidence stabilized in women

Saved in:
Bibliographic Details
Published in:Cancer epidemiology, biomarkers & prevention biomarkers & prevention, 2017-03, Vol.26 (3), p.435-436
Main Authors: Guo, F, Cofie, LE, Berenson, AB
Format: Article
Language:English
Subjects:
Age
Cancer vaccines
Cervical cancer
Cervix
Epidemiology
Females
Histology
Human papillomavirus
Hurricanes
Immunization
Incidence
Invasiveness
Papillomaviridae
Squamous cell carcinoma
Trends
Vaccination
Vaccines
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Human papillomavirus (HPV) vaccine has been recommended for girls 11–12 years of age since 2006, with catch-up vaccination up to 26 years, to protect against most common types of HPV that cause cervical cancer. Cervical cancer incidence stabilized in women
ISSN:1055-9965
1538-7755
DOI:10.1158/1055-9965.EPI-17-0026